131 related articles for article (PubMed ID: 22053979)
1. Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection.
Cao Y; Xia Q; Chen C; Yang Y
Acta Paediatr; 2012 Mar; 101(3):242-6. PubMed ID: 22053979
[TBL] [Abstract][Full Text] [Related]
2. Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.
Benito J; Luaces-Cubells C; Mintegi S; Astobiza E; Martinez-Indart L; Valls-Lafont A; García-García JJ
Eur J Pediatr; 2013 Nov; 172(11):1441-9. PubMed ID: 23793138
[TBL] [Abstract][Full Text] [Related]
3. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
[TBL] [Abstract][Full Text] [Related]
4. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular biomarkers in preeclampsia at triage.
Wellmann S; Benzing J; Fleischlin S; Morgenthaler N; Fouzas S; Bührer CA; Szinnai G; Burkhardt T; Lapaire O
Fetal Diagn Ther; 2014; 36(3):202-7. PubMed ID: 24853905
[TBL] [Abstract][Full Text] [Related]
6. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
Koch L; Dabek MT; Frommhold D; Poeschl J
Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
[TBL] [Abstract][Full Text] [Related]
7. The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea.
Wu AH; Tabas J; Stein J; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Nowak R; Peacock WF; Ponikowski P; Moeckel M; Hogan C; Filippatos GS; Di Somma S; Anand I; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
Biomarkers; 2012 Sep; 17(6):490-7. PubMed ID: 22616939
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
9. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.
Wang RL; Kang FX
Chin J Traumatol; 2010 Jun; 13(3):152-7. PubMed ID: 20515592
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
11. Cord blood plasma reference intervals for potential sepsis markers: pro-adrenomedullin, pro-endothelin, and pro-atrial natriuretic peptide.
Miguel D; Prieto B; Costa M; Coto D; Alvarez FV
Clin Biochem; 2011 Mar; 44(4):337-41. PubMed ID: 21211519
[TBL] [Abstract][Full Text] [Related]
12. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.
Zhang F; Li X; Ochs T; Chen L; Liao Y; Tang C; Jin H; Du J
J Am Coll Cardiol; 2012 Jul; 60(4):315-20. PubMed ID: 22813609
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality.
Artunc F; Nowak A; Mueller C; Breidthardt T; Twerenbold R; Wagner R; Peter A; Haering HU; Ebmeyer S; Friedrich B
PLoS One; 2014; 9(1):e86148. PubMed ID: 24465926
[TBL] [Abstract][Full Text] [Related]
15. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI).
Baldenhofer G; Laule M; Mockel M; Sanad W; Knebel F; Dreger H; Leonhardt F; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V
Clin Chem Lab Med; 2017 Feb; 55(2):275-283. PubMed ID: 27522619
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption.
Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C
J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375
[TBL] [Abstract][Full Text] [Related]
17. Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals.
Bhandari SS; Davies JE; Struck J; Ng LL
Biomarkers; 2011 May; 16(3):281-7. PubMed ID: 21438719
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular biomarkers predict fragility fractures in older adults.
Johansson M; Ricci F; Di Martino G; Rogmark C; Sutton R; Hamrefors V; Melander O; Fedorowski A
Heart; 2019 Mar; 105(6):449-454. PubMed ID: 30322844
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular biomarkers and risk of low-energy fractures among middle-aged men and women-A population-based study.
Härstedt M; Holmberg A; Rogmark C; Sutton R; Melander O; Hamrefors V; Fedorowski A
PLoS One; 2018; 13(9):e0203692. PubMed ID: 30216373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
